NTV Asset Management LLC Decreases Position in iShares Biotechnology ETF $IBB

NTV Asset Management LLC trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the second quarter, Holdings Channel reports. The firm owned 52,968 shares of the financial services provider’s stock after selling 1,465 shares during the quarter. NTV Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $6,701,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of IBB. Citigroup Inc. boosted its position in shares of iShares Biotechnology ETF by 88.5% in the 1st quarter. Citigroup Inc. now owns 3,208,144 shares of the financial services provider’s stock worth $410,322,000 after buying an additional 1,505,976 shares in the last quarter. Commonwealth Equity Services LLC boosted its position in shares of iShares Biotechnology ETF by 12.0% in the 1st quarter. Commonwealth Equity Services LLC now owns 194,516 shares of the financial services provider’s stock worth $24,879,000 after buying an additional 20,915 shares in the last quarter. Jones Financial Companies Lllp boosted its position in shares of iShares Biotechnology ETF by 763.3% in the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock worth $19,347,000 after buying an additional 133,744 shares in the last quarter. Generali Investments CEE investicni spolecnost a.s. boosted its position in shares of iShares Biotechnology ETF by 35.0% in the 2nd quarter. Generali Investments CEE investicni spolecnost a.s. now owns 116,115 shares of the financial services provider’s stock worth $14,690,000 after buying an additional 30,115 shares in the last quarter. Finally, MAI Capital Management lifted its holdings in shares of iShares Biotechnology ETF by 4.2% in the first quarter. MAI Capital Management now owns 98,158 shares of the financial services provider’s stock valued at $12,554,000 after purchasing an additional 3,923 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.9%

Shares of NASDAQ IBB opened at $151.00 on Friday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $151.62. The firm’s 50-day moving average is $139.19 and its two-hundred day moving average is $130.00.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a $0.0828 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.